Shattuck Labs, Inc. (STTK) stock
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.59−0.07 (-1.50%)
Close on Nov 17, 2026Market cap $460.67MP/E –Yield –
Shattuck Labs revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Shattuck Labs's revenue for the twelve months ending Jun 30, 2026 was $1.00M, down 66.6% year over year. For fiscal 2025 it was $1.00M, down 82.5% from the year before. The highest annual figure on record is $30.02M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00M | -82.5% |
| FY2024 | Dec 31, 2024 | $5.72M | +245.3% |
| FY2023 | Dec 31, 2023 | $1.66M | +154.1% |
| FY2022 | Dec 31, 2022 | $652.00K | -97.8% |
| FY2021 | Dec 31, 2021 | $30.02M | +202.2% |
| FY2020 | Dec 31, 2020 | $9.93M | +0.5% |
| FY2019 | Dec 31, 2019 | $9.89M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $1.00M | -66.6% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $3.00M | +336.9% |
| Q2 FY2024 | Jun 30, 2024 | $1.61M | +704.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.12M | +1856.1% |
| Q4 FY2023 | Dec 31, 2023 | $714.00K | +83.1% |
| Q3 FY2023 | Sep 30, 2023 | $686.00K | +223.6% |
| Q2 FY2023 | Jun 30, 2023 | $200.00K | +300.0% |
| Q1 FY2023 | Mar 31, 2023 | $57.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $390.00K | -98.7% |
| Q3 FY2022 | Sep 30, 2022 | $212.00K | -88.8% |
| Q2 FY2022 | Jun 30, 2022 | $50.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $30.08M | +2141.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.90M | -22.0% |
| Q2 FY2021 | Jun 30, 2021 | -$4.23M | -233.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.27M | -23.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.34M | -52.4% |
| Q3 FY2020 | Sep 30, 2020 | $2.44M | +36.5% |
| Q2 FY2020 | Jun 30, 2020 | $3.18M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.98M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.82M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.78M | – |
See a number that looks wrong?